Abstract:Objective To evaluate the clinical value of contrast enhanced ultrasound(CEUS) for patients with hepatocellular carcinoma in identifying the ablation range and designing the treatment protocol before radiofrequency ablation(RFA) treatment and to compare the efficacy of RFA after CEUS with the efficacy of RFA after fundamental ultrasonography(US) without contrast.Methods One hundred sixty-one patients with hepatocellular carcinoma(HCC) were suitable for percutaneous RFA and underwent US-guided RFA treatment.CEUS was performed for 77 patients pre-treatment(CEUS group) and fundamental US without contrast enhancement was performed for the remaining 84 patients pre-treatment(non-CEUS group).There were no significant differences in clinical data between the two groups;the average diameters of the lesions in CEUS group and non-CEUS group were(3.6±1.2) cm and(3.5±1.1) cm,respectively.Regular follow-up after treatment was performed using fundamental US and contrast-enhanced computed tomography(CECT) or CEUS(or both).No residue or local recurrence on CECT at least 6 months after treatment was classified as complete ablation.Results In the CEUS group,77 cases with 105 lesions were treated with RFA.There were 59 lesions(56.2%) that were larger during the arterial phase and 49 lesions(46.7%) that had a more irregular shape during the arterial phase than in fundamental US.Feeding vessels were detected with CEUS in 37 of 52 lesions larger than 3.5 cm(71.1%).CEUS showed 16 small lesions(≤2.0 cm) in 10 cases,5 of which had 5 hepatic distant recurrences after RFA which coexisted with liver cirrhosis.Another 5 cases had 11 satellite lesions around the main tumor.The average number of RFA sessions in the CEUS group and non-CEUS group were 1.2 and 1.5 respectively.During the 6 to 36 months of follow-up,the complete ablation rate in the CEUS group was significantly higher than that in the non-CEUS group(95.4% vs 87.8%,P=0.042).The average survival time in the CEUS group was longer than that of non-CEUS group [(34.2±1.2) months vs(30.2±1.6) months,P=0.028].Conclusions CEUS is used to accurately identify the tumor invasive range and sensitively detect minute or satellite lesions and the feeding vessel of the tumor.CEUS provides important information and evidence for planning the RFA protocol and may improve the efficacy of RFA treatment of liver tumors.

Improvement of Ablative Margins by the Intraoperative Use of CEUS-CT/MR Image Fusion in Hepatocellular Carcinoma

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

Application of imaging fusion combining CEUS and MRI in detection of HCCs undetectable by conventional ultrasound.

Feasibility of CT-CT fusion imaging for evaluation of the cryoablation margins in visible hepatocellular carcinoma on unenhanced CT images: Initial experience

Contrast-enhanced ultrasonography guidance avoids US-CT/MR fusion error for percutaneous radiofrequency ablation of hepatocellular carcinoma

Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound

Fusion Imaging-Guided Radiofrequency Ablation for Residual Hepatocellular Carcinoma Invisible on Ultrasound after Transcatheter Arterial Chemoembolization.

Improving Ablation Safety for Hepatocellular Carcinoma Proximal to the Hilar Bile Ducts by Ultrasound-MR Fusion Imaging: A Preliminary Comparative Study

Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.

Assessment of the Cryoablation Margin Using MRI–CT Fusion Imaging in Hepatic Malignancies

Contrast-enhanced ultrasonography in the characterization of focal liver lesions before microwave ablation therapy

Feasibility of 3D US/CEUS-US/CEUS fusion imaging-based ablation planning in liver tumors: a retrospective study

Precise liver tumor ablation: the clinical potential of US-US overlay fusion guidance

Contrast Comparison of CEUS and CECT or CEMRI in Assessment of Tumor Vascularity and Response to Thermal Ablation in Patients with Hepatocellular Carcinoma : A Multi-centre Study in China

CEUS-Based Radiomics Can Show Changes in Protein Levels in Liver Metastases after Incomplete Thermal Ablation.

The application of dynamic contrast-enhanced ultrasonography in immediate distinguishing residual tumour from benign periablational enhancement after hepatocellular carcinoma radiofrequency ablation

Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings

Clinical value of contrast enhanced ultrasound for identifying ablation range and designing treatment protocol of radiofrequency ablation in hepatocellular carcinoma

Contrast-enhanced Ultrasound in the Assessment of Efficacy of Radiofrequency Ablation for Hepatocellular Carcinoma

Contrast-enhanced ultrasonography–CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome

Application of contrast-enhanced ultrasound and enhanced CT in diagnosis of liver cancer and evaluation of radiofrequency ablation